Tomoyuki Asada, Eric R. Zhao, Adin M. Ehrlich, Adrian Lui, Andrea Pezzi, Sereen Halayqeh, Tarek Harhash, Olivia C. Tuma, Kasra Araghi, Todd J. Albert, James Farmer, Russel C. Huang, Harvinder Sandhu, Han Jo Kim, Francis C. Lovecchio, James E. Dowdell, Sravisht Iyer, Sheeraz A. Qureshi
Neurospine 2025;22(1):3-13. Published online March 31, 2025
Objective While minimally invasive-transforaminal lumbar interbody fusion (MIS-TLIF) has shown superiority in key clinical metrics over the open approach, evidence regarding patient-reported outcomes remains limited. This study compared postoperative recovery trajectories and symptomatic improvement phases between MIS and open TLIF.
Methods This retrospective review included patients who underwent single-level MIS or open TLIF. Oswestry Disability Index (ODI) and Numerical Rating Scale (NRS) for back and leg pain were collected preoperatively and postoperatively. Segmented regression analysis with mixed-effects modeling, allowing for identification of distinct recovery phases, compared symptomatic trends between approaches.
Results Of 324 patients (268 MIS, 56 open), baseline demographics were similar except for greater preoperative leg pain in the MIS group (NRS: 6.0 vs. 5.0, p = 0.027). A segmented regression model identified 4 ODI recovery phases: postoperative disability phase (PDP, day 0 to 13), early improvement phase (day 13 to 28), late improvement phase (day 28 to 110), and plateau phase (later than day 110). The MIS group exhibited significantly lower disability exacerbation during PDP (β = 0.93 vs. 1.42 points per day, p = 0.008). Additionally, the plateau of NRS back occurred significantly earlier in the MIS group than in the open group (MIS, 26.7 ± 2.6 days vs. open, 51.7 ± 6.6 days, p < 0.001).
Conclusion MIS-TLIF resulted in lower postoperative disability during the first 2 weeks compared to the open approach. Furthermore, low back pain achieved an earlier plateau in back pain by about 4 weeks in the MIS approach.
Citations
Citations to this article as recorded by
Multifidus Muscle Atrophy Predicts Spinal Cage Subsidence After Lumbar Fusion Cong Zhang, Chengming Li, Xiaotao Wu, Xiaozhi Sun Journal of Pain Research.2026; Volume 19: 1. CrossRef
Biomaterials and Noncoding RNA: The “Repair‐Alliance” Perspective in Intervertebral Disc Degeneration Chen Liu, Zhengguang Li, Yongbo Zhang, Tianyi Ji, Hua Sun, Gen Wei, Liang Zhang, Juqun Xi Advanced Healthcare Materials.2026;[Epub] CrossRef
Modified Integrated Health State Suggests Lower Cumulative Neck Pain–Related Disability After Cervical Disk Replacement Compared With Anterior Cervical Diskectomy and Fusion Tomoyuki Asada, Adin M. Ehrlich, Sereen Halayqeh, Eric R. Zhao, Adrian T. H. Lui, Andrea Pezzi, Austin C. Kaidi, Kasra Araghi, Vishaal Nayagam, Roger Freeman, Olivia C. Tuma, Tarek Harhash, Harvinder S. Sandhu, Todd J. Albert, Han Jo Kim, James C. Farmer, Neurosurgery.2026;[Epub] CrossRef
Efficacy of low-dose Escherichia coli-derived recombinant human bone morphogenetic protein-2 in minimally invasive transforaminal lumbar interbody fusion Tae Hoon Kang, Jeongwoon Han, Minjoon Cho, Jae Hyup Lee European Spine Journal.2025;[Epub] CrossRef